Year
2025202420232022202120202019201820172016201520142013201120102009200820072006200520042003200220012000
Edition number
№s3-12№s2-12№s1-12№20 (253)№19 (252)№17 (250)№16 (249)№15 (248)№14 (247)№13 (246)№12 (245)№11 (244)№10 (243)№9 (242)№8 (241)№7 (240)№6 (239)№5 (238)№4 (237)№3 (236)№2 (235)№1 (234)
№18 (251) / 2012
S. V. Kamzolova
Opening remarksA.V.Filimonyuk
Current Potentials For The Drug Therapy Of Adrenocortical Cancer10-13
O.V. Zhukova 1, S.A. Bulgakova 2, T.L. Khokhlova 2
Some Approaches For Creating Of Pharmacologically Active Polymer Derivatives Of Medicines With Antitumor Activity14-19
N. N. Semenov
Avastin (bevacizumab) In The Treatment Of Tumors Of The Stomach And Pancreas20-23
I.G.Rusakov, A.A.Kosov, S. V. Mishugin
Place Of Drug Therapy In The Prevention And Treatment Of Bone Complications Of Prostate Cancer24-27
E.I.Kovalenko, E.F.Satirova, E.V.Artamonov, L.V.Manzyuk
Chemotherapy Of Anthracycline- And Taxan-resistant Breast Cancer28-31
A.A.Kolomeytseva 1, I.M.Gagarin 1, E.V.Reutova 2, V. V. Mochalnikova 1, N. N. Mazurenko 1, V.A.Gorbunova 1
Own Experience Of Use Of Egfr Tyrosine Kinase Inhibitors And Bevacizumab In The Treatment Of Patients With Non-small Cell Lung Cancer32-36
Yu.A.Barsukov 1, S.S. Gordeyev 2, M.Yu. Fedyanin 1
Strategies Of Development Of Programs Of Complex Treatment Of Patients With Primary Unresectable Locally Advanced Rectal Cancer37-41
A.N. Polyakov,, D.V.Podluzhny,, K.G. Mamontov, D.G. Borodin, Yu.I. Patyutko
Combined Treatment Of Colorectal Cancer Patients With Liver Metastases42-49
T.Yu. Semiglazova 1, V.V. Semiglazov 2, L.V.Filatova 1, P.V. Krivorotko 1, V.V. Klimenko 1; M.L. Gershanovich 1, V.F. Semiglazov 1
A New Approach To The Overcoming Resistance To Hormone Therapy Of Breast Cancer50-55
E.I. Borisova 1, S.L. Gutorov 1, A.Yu. Vorontsov 2
Hormonal Treatment Of Breast Cancer: Optimal Sequence And Issues Of Overcoming The Resistance56-60
Yu.A. Alekseyeva, R.I. Vabishchevich
Delayed-onset Neutropenia Associated With Rituximab Therapy62-64
I.S.Romanov
Chemotherapy Of Head And Neck Squamous Cell Carcinoma (hnscc)65-68
L.G.Zhukova, M.R. Lichinitser
Adjuvant Therapy With Trastuzumab For Early-stage Breast Cancer: 12 Or 24 Months (based On Esmo Data, Vienna, October, 2012)69-70
V.F.Semiglazov 1, V. V. Semiglazov 2
Adjuvant Hormonal Therapy In Perimenopausal Women With Er-positive Breast Cancer71-74
N.S. Besova, S.V. Khokhlova, V.A. Gorbunova
Herceptin In The Treatment Of Disseminated Her2-positive Gastric Cancer: A Clinical Case Of Successful Treatment Of Elderly Patient75-79
